GSK2800528 – first doses in humans & comparison with Humira; ver 2

• Research type

  Research Study

• Full title

  A study to evaluate the pharmacokinetics, safety and tolerability, immunogenicity, and pharmacodynamics of GSK2800528 in healthy subjects. (12-023)

• IRAS ID

  130430

• Contact name

  Malcolm Boyce

• Contact email

  vparker@hmrlondon.com

• Sponsor organisation

  GlaxoSmithKline

• Eudract number

  2012-004474-26

• REC name

  Scotland A REC

• REC reference

  13/SS/0108

• Date of REC Opinion

  9 Jul 2013

• REC opinion

  Further Information Favourable Opinion